Smart Pills Market to hit $650 million by 2025, at CAGR of 12.1% With Top Companies Medtronic Plc., Olympus Corporations

The surge in demand toward more efficient as well as non-invasive diagnostic procedures supplement the need for smart pills across the globe. Moreover, significant rise in gastrointestinal disorders worldwide and optimized reimbursement policies for the use of smart pills further boost the growth of the market.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/1138?reqfor=covid

The global smart pills market generated $256.7 million in 2017, and is estimated to reach $650.3 million by 2025, growing at a CAGR of 12.1% from 2018 to 2025.

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

Increasing prevalence of gastrointestinal (GI) disorders among geriatric population and growing requirement for diagnostic examinations drive the growth of the market. However, long approval process and high cost related to smart pills hinder the market growth. On the other hand, augmenting need for technological advancements and heavy inflow of R&D investments would provide new opportunities to the market.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1138

Capsule endoscopy segment to lead throughout the forecast period

Capsule endoscopy segment contributed more than half of the total market share in 2017, owing to the increased adoption of smart pills for the diagnosis of GI diseases. This segment would continue to dominate throughout the forecast period. However, patient monitoring segment would register the fastest CAGR of 12.7% from 2018 to 2025 due to extensive use of smart pills for monitoring pH, body temperature, and other parameters, countering medication non-adherence, and diagnosing diseases. The drug delivery application segment would grow at a steady rate during the forecast period.

Small intestine segment to dominate in terms of revenue by 2025

Smart pills for small intestine segment accounted for nearly half of the total market share in 2017, owing to the prevalence of small intestinal disorders including Crohn's Disease, celiac disease, and others. This segment would remain dominant in terms of revenue through 2025. Moreover, smart pills for large intestine segment would register the highest CAGR of 13.6% from 2018 to 2025, owing to rise in incidence of large intestinal disorders including colon cancer and others. The other target areas analyzed in the report include esophagus and stomach.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1138

Small bowel diseases segment to remain dominant during the forecast period

Small bowel diseases segment accounted for nearly half of the total market share in 2017, owing to rise in usage of capsule endoscopy for treatment. This segment would remain dominant during the forecast period. Colon diseases segment would register the highest CAGR of 13.6% from 2018 to 2025, owing to rise in incidence of colon cancer and others. The research analyzes esophageal diseases and others.

Diagnostic centers segment to contribute its lion's share by 2025

Diagnostic centers segment accounted for more than half of the total market share in 2017 and is expected to continue its lion's share through 2025. This is attributed to the rise in adoption of capsule endoscopes for the diagnosis of GI tract disorders along with safe, cost-efficient, and less time-consuming protocols followed at diagnostic centers. However, hospitals segment would grow at the highest CAGR of 12.6% from 2018 to 2025, owing to the increase in hospitalization rate for disease diagnosis. The research centers segment would grow at a steady rate during the forecast period.

North America to garner the highest revenue, Asia-Pacific to grow the fastest

Easy access and rapid adoption of the newest endoscopic technologies in North America have enabled the region to contribute nearly half of the total market share 2017. However, Asia-Pacific would register the highest CAGR of 14% from 2018 to 2025, owing to rise in prevalence of GI disorders and huge investments in R&D activities by major industry players.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/smart-pills-market

The Major Key Players Are:

Proteus Digital Health, HQ, Inc., CapsoVision, Inc., Medtronic Plc., Olympus Corporations, IntroMedic Co., Ltd, RF Co., Ltd, JINSHAN Science & Technology, Check Cap, and Koninklijke Philips N.V.

The Other Key Players Are:

GE Healthcare, NOVARTIS AG, Fujifilm Holdings Corporation, Bio-Images Drug Delivery (BDD) Limited, Quotient Clinical Ltd., Innovative Devices LLC, and PENTAX Medical.

Similar Reports:

Liquid Biopsy Market : https://www.pharmiweb.com/press-release/2020-09-14/liquid-biopsy-market-to-see-record-break-revenue-3-805-million-by-2023

Anesthesia Devices Market : https://www.pharmiweb.com/press-release/2020-09-14/anesthesia-devices-market-value-to-hit-15-463-million-by-2023-at-cagr-of-71-amr

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.